• Measure Summary
  • NQMC:011016
  • 2017 Feb

Non-Hodgkin lymphoma: percent of lymphoma patients of childbearing age who received treatment for lymphoma and who were offered fertility counseling prior to starting treatment OR documentation in the medical record why such counseling was unnecessary.

American Society of Hematology

  • Measure Summary
  • NQMC:006375
  • 2009 Jun

Pancreatic cancer: percentage of patients undergoing cancer-directed resection for whom the tumor histology is recorded.

American College of Surgeons

  • Measure Summary
  • NQMC:008564
  • 2012 Apr

Infection control after hematopoietic cell transplantation (HCT): percentage of patients who had HCT and were herpes simplex virus seropositive and/or varicella-zoster virus seropositive and prophylaxis was prescribed.

American Society for Blood and Marrow Transplantation

  • Measure Summary
  • NQMC:009992
  • 2015 Mar

Stroke: percentage of SAH and ICH stroke patients for whom a severity measurement is performed prior to surgical intervention in patients undergoing surgical intervention and documented in the medical record, OR documented within 6 hours of arrival at the hospital ED for patients who do not undergo surgical intervention.

The Joint Commission

  • Measure Summary
  • NQMC:007191
  • 2009 Nov

Melanoma: percentage of patients with a melanoma less than or equal to 1 mm thick (i.e., T1) for whom the surgical excision margins are 1 cm (or the specific anatomic or cosmetic factors that limit margin distance are noted).

American College of Surgeons

  • Measure Summary
  • NQMC:007211
  • 2009 Nov

Melanoma: percentage of patients with melanoma who have biopsy-proven, palpable nodal disease who do not undergo sentinel lymph node biopsy (SLNB).

American College of Surgeons

  • Measure Summary
  • NQMC:011019
  • 2017 Feb

Myelodysplastic syndromes (MDS): percentage of MDS patients for whom an established pathologic classification/risk prognostication system was used to help plan therapeutic options.

American Society of Hematology

  • Measure Summary
  • NQMC:007188
  • 2009 Nov

Melanoma: percentage of patients with a melanoma in situ (i.e., Tis) for whom the surgical excision margins are 5 mm (or the specific anatomic or cosmetic factors that limit margin distance are noted).

American College of Surgeons

  • Measure Summary
  • NQMC:011013
  • 2017 Feb

Non-Hodgkin lymphoma: percent of lymphoma patients assigned a specific stage using Ann Arbor system including presence/absence of B symptoms AND having bone marrow biopsy or documentation why bone marrow biopsy was unnecessary or contraindicated.

American Society of Hematology

  • Measure Summary
  • NQMC:006378
  • 2009 Jun

Pancreatic cancer: percentage of patients undergoing cancer-directed resection for whom the margin status is recorded.

American College of Surgeons

  • Measure Summary
  • NQMC:009995
  • 2015 Mar

Stroke: percentage of SAH patients for whom nimodipine treatment was administered within 24 hours of arrival at the hospital.

The Joint Commission

  • Measure Summary
  • NQMC:007194
  • 2009 Nov

Melanoma: percentage of patients to undergo a sentinel lymph node biopsy (SLNB) for melanoma for whom lymphoscintigraphy is performed to identify the draining nodal basin(s) when drainage to more than one basin is possible.

American College of Surgeons

  • Measure Summary
  • NQMC:007402
  • 2010 Jun

Breast cancer: the proportion of patients with breast cancer (invasive or in situ) who had a pre-operative definitive diagnosis (B5 or C5).

European Society of Breast Cancer Specialists

  • Measure Summary
  • NQMC:006401
  • 2009 Jun

Pancreatic cancer: percentage of patients undergoing resection for whom the surgeon documents intraoperative findings in the operative note including the absence of 1) regional arterial involvement, 2) metastatic disease (liver, peritoneal, omental), and 3) distant adenopathy.

American College of Surgeons

  • Measure Summary
  • NQMC:010127
  • 2015 Oct
  • NQF-Endorsed Measure

Stroke: percent of ischemic and hemorrhagic stroke patients who received VTE prophylaxis or who have documentation why no VTE prophylaxis was given the day of or the day after hospital admission.

The Joint Commission

  • Measure Summary
  • NQMC:007200
  • 2009 Nov

Melanoma: percentage of patients who undergo an axillary lymph node dissection (LND) or completion lymph node dissection (CLND) for melanoma for whom at least 10 regional lymph nodes are resected and pathologically examined.

American College of Surgeons

  • Measure Summary
  • NQMC:006384
  • 2009 Jun

Pancreatic cancer: percentage of patients undergoing resection for whom the College of American Pathologists checklist or equivalent reporting system is followed and fully documented.

American College of Surgeons

  • Measure Summary
  • NQMC:010000
  • 2015 Mar

Heart failure (HF): percentage of HF patients discharged from a hospital inpatient setting to home or home care for whom a care transition record is transmitted to a next level of care provider within 7 days of discharge containing the specified information.

The Joint Commission

  • Measure Summary
  • NQMC:006381
  • 2009 Jun

Pancreatic cancer: percentage of patients undergoing resection of a pancreatic head lesion for whom the surgeon documents complete removal of all pancreatic tissue, lymph nodes, and connective tissue between the edge of the uncinate process and the right lateral wall of the superior mesenteric artery in the operative note.

American College of Surgeons

  • Measure Summary
  • NQMC:011022
  • 2017 Feb

Myelodysplastic syndromes (MDS): percentage of higher-risk MDS patients receiving azacitidine or decitabine.

American Society of Hematology